Taiho Oncology, Inc.

Taiho Oncology, Inc. is a pharmaceutical company focused on improving the lives of people with cancer and their families and caregivers. It develops and commercializes orally administered anti-cancer medicines for multiple tumor types, and advances a pipeline of small-molecule clinical candidates targeting solid tumors and blood cancers, alongside additional preclinical programs. The company operates as the North American oncology commercial organization of its parent group.